Rajendra Prasad Nagarajan

17PUBLICATIONS
21CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesGene and molecular therapyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 08, 2026
Deinoxanthin Overcomes P-Glycoprotein-Mediated Multidrug Resistance in Breast Cancer Cells.

|Mar 16, 2026
Drug repurposing in oncology: Bridging computational discovery to clinical application.

Sugumar Baskar, N Rajendra Prasad

|Nov 13, 2024
Solasodine Downregulates ABCB1 Overexpression in Multidrug Resistant Cancer Cells Via Inhibiting Nrf2/Keap1 Signaling Pathway.

Pradhapsingh Bharathiraja, Sugumar Baskar, N Rajendra Prasad

|Oct 09, 2024
Sensitization of Multidrug Resistant Cancer Cells to Doxorubicin Using Ebselen by Disturbing Cellular Redox Status.

Sugumar Baskar, Pradhapsingh Bharathiraja, N Rajendra Prasad

|Feb 21, 2024
Andrographolide reverts multidrug resistance in KBChR 8-5 cells through AKT signaling pathway.

Deepa S Lakra, Pradhapsingh Bharathiraja, T Dhanalakshmi

|Jan 25, 2024
Auranofin sensitizes breast cancer cells to paclitaxel mediated cell death via regulating FOXO3/Nrf2/Keap1 signaling pathway.

N Deepika, N Rajendra Prasad, T Radhiga

Pageof 3

Frequent Collaborators

3 joint publications

Sugumar Baskar

2 joint publications

Pradhapsingh Bharathiraja

1 joint publications

Naziya Begum

1 joint publications

Priya Yadav